Artificial cells, encapsulation, and immobilization

Annals of the New York Academy of Sciences

Volumn 875, Issue , 1999, Pages 71-83

  Chang, Thomas Ming Swi ^a,b  

^a Faculty of Medicine   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; ENZYME; TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTIFICIAL ORGAN; CELL TRANSPLANTATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BINDING; DRUG DELIVERY SYSTEM; ENCAPSULATION; GENE THERAPY; GENETIC MANIPULATION; HEMOPERFUSION; IMMOBILIZED CELL; LIVER CELL; MICROCAPSULE; NONHUMAN; PANCREAS ISLET CELL; RAT;

ANIMALIA;

EID: 0032773567     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08495.x     Document Type: Conference Paper

References (43)

1. 1. CHANG, T.M.S. 1964. Semipermeable microcapsules. Science 146: 524-525.
2. 2. CHANG, T.M.S., F.C. MACINTOSH & S.G. MASON. 1966. Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharmacol. 44: 115-128.
3. 3. CHANG, T.M.S. 1972. Artificial Cells. Charles C Thomas, Publisher. Springfield, IL.
4. 4. CHANG, T.M.S. 1995. Artificial cells with emphasis on bioencapsulation in biotechnology. Biotechnol. Annu. Rev. 1: 267-295.
5. 5. CHANG, T.M.S. 1997. Artificial Cells. In Encyclopedia of Human Biology. R. Dulbecco, Editor-in-Chief. 1: 457-463. Academic Press. San Diego, CA.
6. 6. CHANG, T.M.S. 1975. Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure. Kidney Int. 7: S387-S392.
7. 7. CHANG, T.M.S. 1997. Blood Substitutes: Principle, Methods, Products and Clinical Trials, Vol I. Karger. Basel.
8. 8. CHANG, T.M.S., Ed. 1998. Blood Substitutes: Principles, Methods, Products and Clinical Trials, Vol. 2. Karger. Basel.
9. 9. CHANG, T.M.S. 1998. Modified hemoglobin-based blood substitutes: crosslinked, recombinant and encapsulated hemoglobin. Vox Sanguinis 74(Suppl. 2): 233-241.
10. 10. CHANG, T.M.S. 1971. Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with gtutaraldehyde. Biochem. Biophys. Res. Commun. 44(6): 1531-1536.
11. 11. GOULD, S.A., L.R. SEHGAL, H.L. SEHGAL, R. DEWOSKIN & G.S. Moss. 1998. In Blood Substitutes: Principles, Methods, Products and Clinical Trials. T.M.S. Chang, Ed. 2: 12-28. Karger. Basel.
12. 12. D'AGNILLO, F. & T.M.S. CHANG. 1998. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nature Biotechnol. 16: 667-671.
13. 13. RUDOLPH, A.S., R. RABINOVICI & G.Z. FEUERSTEIN, Eds. 1997. Red Blood Cell Substitutes. Marcel Dekker, Inc. New York.
14. 14. TSUCHIDA, E., Ed. 1995. Artificial Red Cells. John Wiley & Sons. New York.
15. 15. CHANG, T.M.S. & W.P. Yu. 1996. Biodegradable polymer membrane containing hemoglobin for blood substitutes. US Patent 5670173, September 23, 1997.
16. 16. CHANG, T.M.S. & M.J. POZNANSKY. 1968. Semipermeable microcapsules containing catalase for enzyme replacement in acatalsaemic mice. Nature 218(5138): 242-245.
17. 17. CHANG, T.M.S. 1971. The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma. Nature 229(528): 117-118.
18. 18. LANZA, R.P. & D.K.C. COOPER. 1998. Xenotransplantation of cells and tissues: application to a range of diseases, from diabetes to Alzheimer's. Mol. Med. Today 4: 39-45.
19. 19. PROKOP, A., D. HUNKELER & A.D. CHERRINGTON, Eds. 1997. Bioartificial Organs: Science, Medicine and Technology. Ann. N.Y. Acad. Sci. 831.
20. 20. SUN, A.M. 1997. Microencapsulation of Cells: medical applications. Ann. N.Y. Acad. Sci. 831: 271-279.
21. 21. COLTON, C.K. 1996. Implantable biohybrid artificial organs. Cell Transplant. 4: 415-436.
22. 22. DIONNE K.E., B.M. CAIN, R.H. LI, W.J. BELL, E.J. DOHERTY, D.H. REIN, M.J. LYSAGHT & F.T. GENTILE. 1996. Transport characterization of membranes for immunoisolation. Biomaterials 17: 257-266.
23. 23. PROKOP, A., D. HUNKELER, S. DIMARI, M.A. HARALSON & T.C. WANG. 1998. Water soluble polymers for immunoisolation I: complex coacervation and cytotoxicity. Adv. Polym. Sci. 136:2-51.
24. 24. HAGIHARA, Y., Y. SAITOH, H. IWATA, T. TAKI, S. HIRANO, N. ARITA & T. HAYAKAWA, 1997. Transplantation of xenogeneic cells secreting beta-endorphin for pain treatment: analysis of the ability of components of complement to penetrate through polymer capsules. Cell Transplant. 6: 527-530.
25. 25. COROMILI, V. & T.M.S, CHANG. 1993. Polydisperse dextran as a diffusing test solute to study the membrane permeability of alginate polylysine microcapsules. Biomater. Artif. Cells Immun. Biotechnol. 21: 427-444.
26. 26. AEBISCHER, P., M. SCHLUEP, N. DEGLON, J.M. JOSEPH, L. HIRT, B. HEYD, M. GODDARD, J.P. HAMMANG, A.D. ZURN, A.C. KATO, F. REGLI & E.E. BAETGE. 1996. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 2: 696-699.
27. 27. VERMA, I.M & N. SOMIA. 1997. Gene therapy - promises, problems and prospects. Nature 389: 239-242.
28. 28. REIMER, D.L., M.B. BALLY & S.M. SINGH. 1997. Human gene therapy: principles and modern advances. Biotechnol. Annu. Rev. 3: 59-110.
29. 29. BASIC, D., I. VACEK & A.M. SUN. 1996. Microencapsulation and transplantation of genetically engineered cells: a new approach to somatic gene therapy. Artif. Cells Blood Substit. Immobil. Biotechnol. 24: 219-255.
30. 30. TAN, S.A., N. DEGLON, A.D. ZURN, E.E. BAETGE, B. BAMBER, A.C. KATO & P. AEBIscher. 1996. Rescue of motoneurons from axotomy-induced cell death by polymer encapsulated cells genetically engineered to release CNTF, Cell Transplant. 5: 577-587
31. 31. ABISCHER, P., N.A. POCHON, B. HEYD, N. DEGLON, J.M. JOSEPH, A.D. ZURN, E.E. BAETGE, J.P. HAMMANG, M. GODDARD, M. LYSAGHT, F. KAPLAN, A.C. KATO, M. SCHLUEP, L. HIRT, F. REGLI, F. PORCHET & N. DE TRIBOLET. 1996. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF. Hum. Gene Ther. 1: 851-860.
32. 32. SAITOH, Y., T. TAKI, N. ARITA, T. OHNISHI & T. HAYAKAWA. 1995. Cell therapy with encapsulated xenogeneic tumor cells secreting beta-endorphin for treatment of peripheral pain. Cell Transplant. Suppl. 1: S13-S17.
33. 33. OKADA, N., H. MIYAMOTO, T. YOSHIOKA, A. KATSUME, H. SAITO, K. YOROZU, O. UEDA, N. ITOH, H. MIZUGUCHI, S. NAKAGAWA, Y. OHSUGI & T, MAYUMI. 1997. Cytomedical therapy for IgG1 plasmacytosis in human interleukin-6 transgenic mice using hybridoma cells microencapsulated in alginate-poly(L)lysine-alginate membrane. Biochim. Biophys. Acta 1360 (1): 53-63.
34. 34. AL-HENDY, A., G. HORTELANO, G.S, TANNENBAUM & P.L. CHANG.. 1966. Growth retardation - an unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts. Hum. Gene Therap. Jan. 7(1): 61-70.
35. 35. DATE, I., T. OHMOTO, T. IMAOKA, T. SHINGO & D.F. EMERICH. 1996. Chromaffin cell survival from both young and old donors is enhanced by co-grafts of polymerencapsulated human NGF-secreting cells. Neuroreport 7(11): 813-818.
36. 36. WINN, S.R., J.P. HAMMANG, D.F. EMERICH, A. LEE, R.D. PALMITER & E.E. BAETGE. 1994. Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons, Proc. Natl. Acad. Sci. USA 91(6): 2324-2328.
37. 37. PRAKASH, S. & T.M.S. CHANG. 1996. Microeneapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nature Med. 2 (8): 883-887.
38. 38. CHANG, T.M.S. & S. PRAKASH. 1998. Therapeutic uses of microencapsulated genetically engineered cells. Mol. Med. Today, 4: 221-227.
39. 39. FRIEDMAN, E. A. 1996. Bowl as an artificial kidney. Am. J. Kidney Dis. Dec.: 521-528.
40. 40. SCOOT, B., H. MULROONEY, P. STUART & R.P. HAUSSINGER'S. 1989. Regulation of gene expression and cellular localization of cloned K. aerogens urease. J. Gen. Microbiol. 135: 1769-1776.
41. 41. PRAKASH, S. & T.M.S. CHANG. 1995. Preparation and in-vitro analysis of engineered E. coli DH5 cells, microencapsulated in artificial cells for urea and ammonia removal. Biotechnol. Bioeng. 46: 621-626.
42. 42. PRAKASH, S. & T.M.S. CHANG. 1998. Growth and survival of renal failure rats that received oral microencapsulated genetically engineered E. coli DH5 cells for urea removal. Biomater. Artif. Cells Immobil. Biotechnol. 26: 35-52.
43. 43. WRONG, O.M., C.J. EDMONDS & V.S. CHADWICK, Eds. 1981. The Large Intestine. MTP Press. Lancaster.